Ontology highlight
ABSTRACT:
SUBMITTER: Reissig TM
PROVIDER: S-EPMC10620118 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature
Reissig Timm M TM Ladigan-Badura Swetlana S Steinberg Anja A Maghnouj Abdelouahid A Li Ting T Verdoodt Berlinda B Liffers Sven T ST Pohl Michael M Wolters Heiner H Teschendorf Christian C Viebahn Richard R Admard Jakob J Casadei Nicolas N Tannapfel Andrea A Schmiegel Wolff W Hahn Stephan A SA Vangala Deepak B DB
Molecular oncology 20230903 11
Although approximately half of all metastatic colorectal cancers (mCRCs) harbour mutations in KRAS or NRAS, hardly any progress has been made regarding targeted treatment for this group over the last few years. Here, we investigated the efficacy of vertical inhibition of the RAS-pathway by targeting epidermal growth factor receptor (EGFR) and mitogen-activated protein kinase kinase (MEK) in patient-derived xenograft (PDX) tumours with primary KRAS mutation. In total, 19 different PDX models comp ...[more]